SKYE
Skye Bioscience, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:50 PM EDT
1.69USD+5.625%(+0.09)11,130
Pre-marketOct 2, 2026 9:19:30 AM EDT
1.54USD-3.750%(-0.06)
Loading…
Loading…
7.31M
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$1.60
Beta
0.87
52-Week High
$39.92 2025-10-03
52-Week Low
$1.50 2026-09-17
SMA 50
$2.77
SMA 200
$5.45
Avg. Vol 10D
66,826
Avg. Vol 30D
83,979
Avg. Vol 90D
68,537
Relative Vol
0.13
4.43M
2.87M
64.84%
117,086
4.08%
1.36
42%/58%
39.23%
18.67%
5.6700%
250,000
27,863
6,459
27,863
Nov 9, 2026 (35d)
Aug 24, 2026 · 1-for-8 (reverse)
Sep 25, 2026
Sep 18, 2026
5am Partners VII, LLC sells $64,733 in Skye Bioscience stock · 
Investing.com
Skye Bioscience director Andrew Schwab sells $64,733 in shares · Investing.com
SKYE Profile
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
SKYE Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.61 | 2026-09-28 | +2.48% | 5.088 |
| 1M | 1.86 | 2026-09-04 | -11.29% | -0.856 |
| 3M | 5.63 | 2026-07-06 | -70.67% | -0.213 |
| 6M | 5.72 | 2026-04-06 | -71.13% | 0.745 |
| 1Y | 38.00 | 2025-10-03 | -95.66% | 0.871 |
| 2Y | 28.40 | 2024-10-04 | -94.19% | — |
| 5Y | 104.00 | 2021-12-31 | -98.41% | 0.327 |
SKYE Stock Summary
Skye Bioscience, Inc. Common Stock (NASDAQ:SKYE) stock price today is $1.65, and today's volume is 11,130. SKYE is up 3.125% today. The 30 day average volume is 83,979. SKYE market cap is $7.31M with 4.43M shares outstanding.